| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |